A new community approach to treat opioid use disorder and prevent HIV.
Official title: Community-Based Opioid Treatment (CBOT): Development and testing of a novel nurse-led model to delivery opioid use disorder treatment and HIV prevention and care in the community setting.
Funded at University of Washington · NIH-11168537 · Data updated 2026-11-12
This study is looking at a new way to help people with opioid use disorder and prevent HIV by bringing care right into the community, using friendly nurses and outreach workers to support those at high risk with medication and services that can really make a difference in their health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project start | June 15, 2025 |
| Project end | May 31, 2029 |
| Funding year | 2025 |
| Award (this year) | $2,332,500 |
| NIH project number | 1DP2DA063123-01 |
| Project ID | NIH-11168537 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who use opioids and are at risk for HIV infection or have HIV.
✕Less likely to help
Patients who do not use opioids or are not at risk for HIV may not benefit from this research.
What this research studies
This research focuses on developing and testing a community-based model for treating opioid use disorder (OUD) and providing HIV prevention and care. It aims to improve retention in treatment by utilizing nurse care managers and community outreach workers to deliver services directly to individuals at high risk. The approach includes the use of buprenorphine, a medication proven to reduce overdose risk and improve HIV care outcomes. By bringing these services into the community, the research seeks to engage more people in care and enhance their health outcomes.
Why it matters
Potential benefit: If successful, this research could significantly improve access to and retention in treatment for individuals with opioid use disorder and those at risk for HIV.
How similar studies have gone: Previous research has shown success with community-based approaches to healthcare delivery, particularly in improving access to treatment for substance use disorders.
Where this research is happening
-
University of Washington
Seattle, United States Active
Researchers
- Principal investigator: Heidari, Omeid — University of Washington
- Study coordinator: Heidari, Omeid
Related research
Other NIH-funded projects on the same topics.
-
Integrating HIV prevention into opioid-use care to protect patients
A multi-institution team will find practical ways to weave HIV prevention like screening and PrEP into care settings where people with opioid use disorder already receive help.
-
Improving HIV Prevention for People with Opioid Use Disorder
This project aims to connect people with opioid use disorder to important HIV prevention services in places where they already receive care.
-
Improving HIV prevention for drug users on probation in Eastern Europe
This study is looking for better ways to help people on probation in Eastern Europe who use drugs stay healthy and prevent HIV, by understanding their needs and finding the best ways to support them.
-
Integrating HIV prevention services into care for people with opioid use disorder
This study is looking at how to make it easier for people with opioid use disorder to get HIV prevention services, like testing and medication, by bringing these services into places they already visit for healthcare, like emergency rooms and clinics.
-
Systems analysis to improve opioid use disorder care after jail release (SAIA-MOUD)
A program to help people with opioid use disorder get better, faster, and safer care after they leave jail.
-
Precise epigenetic drugs for opioid addiction
A tiny, targeted drug approach is being developed to help people with opioid use disorder by rewriting the epigenetic signals in the brain to reduce cravings and relapse risk.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.